Sign inGet started

Yi Kathy

Insider CIK 1697802 · SGMO Senior VP & CFO · THRX Director · CERE Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
THRX Theseus Pharmaceuticals, I D To issuer deriv2024-02-142024-02-1499,634— $00SEC↗
THRX Theseus Pharmaceuticals, I D To issuer deriv2024-02-142024-02-143,250— $00SEC↗
THRX Theseus Pharmaceuticals, I A Award deriv2023-06-132023-06-1319,500— $019,500SEC↗
THRX Theseus Pharmaceuticals, I A Award deriv2023-06-132023-06-133,250— $03,250SEC↗
THRX Theseus Pharmaceuticals, I A Award deriv2022-06-102022-06-1330,000— $030,000SEC↗
THRX Theseus Pharmaceuticals, I A Award deriv2021-10-062021-10-0822,678— $022,678SEC↗
CERE Cerevel Therapeutics Holdi A Award deriv2021-02-032021-02-05216,718— $0216,718SEC↗
CERE Cerevel Therapeutics Holdi A Award deriv2020-10-282020-10-3078,534— $078,534SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2019-05-152019-05-175,000— $0125,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2019-05-152019-05-175,000$4.55 $22.8K30,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2019-05-152019-05-175,000$10.00 $50.0K25,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2019-04-152019-04-165,000— $0130,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2019-04-152019-04-165,000$4.55 $22.8K30,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2019-04-152019-04-165,000$12.11 $60.5K25,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2019-03-152019-03-185,000— $0135,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2019-03-152019-03-185,000$4.55 $22.8K30,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2019-03-152019-03-185,000$10.00 $50.0K25,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2019-03-012019-03-055,000— $0140,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2019-03-012019-03-055,000$10.00 $50.0K25,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2019-03-012019-03-055,000$4.55 $22.8K30,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2019-02-252019-02-27115,500— $0115,500SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2019-02-252019-02-2719,250— $025,512SEC↗
SGMO SANGAMO THERAPEUTICS, INC F Tax w/h2019-01-242019-01-28988$11.10 $11.0K6,262SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2019-01-152019-01-165,000— $0145,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2019-01-152019-01-165,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2019-01-152019-01-165,000$11.04 $55.2K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-12-172018-12-185,000— $0150,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-12-172018-12-185,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-12-172018-12-185,000$11.44 $57.2K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-11-152018-11-165,000— $0155,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-11-152018-11-165,000$10.00 $50.0K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-11-152018-11-165,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-10-152018-10-165,000— $0160,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-10-152018-10-165,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-10-152018-10-165,000$13.97 $69.8K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-09-172018-09-185,000— $0165,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-09-172018-09-185,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-09-172018-09-185,000$14.66 $73.3K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-08-162018-08-175,000— $0170,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-08-162018-08-175,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-08-162018-08-175,000$15.39 $77.0K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-07-162018-07-175,000— $0175,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-07-162018-07-175,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-07-162018-07-175,000$14.77 $73.8K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-06-152018-06-155,000— $0180,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-06-152018-06-155,000$15.67 $78.3K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-06-152018-06-155,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-05-152018-05-165,000— $0185,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-05-152018-05-165,000$15.38 $76.9K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-05-152018-05-165,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-04-162018-04-185,000— $0190,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-04-162018-04-185,000$19.83 $99.1K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-04-162018-04-185,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise deriv2018-03-152018-03-165,000— $0195,000SEC↗
SGMO SANGAMO THERAPEUTICS, INC S Sale2018-03-152018-03-165,000$25.56 $127.8K7,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC M Exercise2018-03-152018-03-165,000$4.55 $22.8K12,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2018-01-242018-01-3143,500— $043,500SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award2018-01-242018-01-317,250— $07,250SEC↗
SGMO SANGAMO THERAPEUTICS, INC A Award deriv2017-02-282017-03-02200,000— $0200,000SEC↗